Profile
Jeffrey Alan Morhet is the founder of ThirdBiotech, Inc., VentureBeacon, Inc. Prior to founding these companies, he worked as Chairman, President & CEO at InNexus Biotechnology, Inc. He also worked as Product Director at Integrated Physician Network and as Vice President & General Manager at Zila, Inc. Morhet is a graduate of Stephen F.
Austin State University.
Former positions of Jeffrey Alan Morhet
| Companies | Position | End |
|---|---|---|
Zila, Inc.
 Zila, Inc. Medical SpecialtiesHealth Technology Zila, Inc., headquartered in Scottsdale, Arizona and founded in 1988, is a diagnostic company that offers prevention, detection and treatment of oral cancer and periodontal disease. Zila manufactures and markets ViziLite Plus with TBlue (“ViziLite Plus”), the company’s product for the detection of oral abnormalities that could lead to cancer. ViziLite Plus is a medical device for use in a popilation risking for oral cancer. Zila designs, manufactures and markets products sold directly to dental professionals for periodontal disease, including the Rotadent Professional Powered Brush, the Pro-Select Platinum ultrasonic scaler and oral pharmaceutical products for both in-office and home-care use | Corporate Officer/Principal | 01/01/2004 |
| Integrated Physician Network | Corporate Officer/Principal | 01/01/2002 |
| ThirdBiotech, Inc. | Founder | - |
| VentureBeacon, Inc. | Founder | - |
| INNEXUS BIOTECHNOLOGY, INC. | Chief Executive Officer | - |
Training of Jeffrey Alan Morhet
| Stephen F. Austin State University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| INNEXUS BIOTECHNOLOGY, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Zila, Inc.
Zila, Inc. Medical SpecialtiesHealth Technology Zila, Inc., headquartered in Scottsdale, Arizona and founded in 1988, is a diagnostic company that offers prevention, detection and treatment of oral cancer and periodontal disease. Zila manufactures and markets ViziLite Plus with TBlue (“ViziLite Plus”), the company’s product for the detection of oral abnormalities that could lead to cancer. ViziLite Plus is a medical device for use in a popilation risking for oral cancer. Zila designs, manufactures and markets products sold directly to dental professionals for periodontal disease, including the Rotadent Professional Powered Brush, the Pro-Select Platinum ultrasonic scaler and oral pharmaceutical products for both in-office and home-care use | Health Technology |
| ThirdBiotech, Inc. | |
| VentureBeacon, Inc. | |
| Integrated Physician Network |
- Stock Market
- Insiders
- Jeffrey Alan Morhet
